Home » Topics » BioWorld Science

BioWorld Science
RSS

New agents for pain and inflammation designed at AstraZeneca

Oct. 23, 2001

Sangamo achieves first milestone in ZFP therapeutics program

Oct. 23, 2001

CPMP lifts Serdolect suspension; Lundbeck moves forward with postmarketing studies

Oct. 23, 2001

Significant beneficial effects reported for PARP inhibitor in animal model of myocardial infarction

Oct. 23, 2001

PARS inhibitors such as PJ-34 may be suitable for the therapy of septic shock

Oct. 23, 2001

Cell Genesys commences phase II trial of GVAX vaccine for pancreatic cancer

Oct. 23, 2001

Vivus updates product pipeline

Oct. 23, 2001

Biogen highlights Q3 developments

Oct. 23, 2001

Ariad presents a new small-molecule antitumor candidate targeting PTEN-deficient cancers

Oct. 23, 2001

Therapeutic efficacy demonstrated for selective ETA receptor antagonist in rat stroke model

Oct. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...